Supported by M&G Investments
Focus on renewable energy
Tackling gender equality, hunger and education issues
Excess capital of £2bn
2018 list revealed
Legacy technology remains primary obstacle
INDUSTRY VOICE: Despite market volatility in Q1, BB Biotech performed very well with an overall return of 8.8% in CHF. Several large biotech companies are currently trading below their fundamental value,and offer an attractive entry level for investors....
Aiming to become livery company
Major industry trend
Increased use of the 'digital ledger'
Number of offers
Judgement made by High Court
Ali Unwin explains the ongoing data-mining fallout that has engulfed Facebook in recent weeks, highlighting the implications for tech companies and the two biggest risks for the social media giant.
Activist investor has built up 5% stake
How to level the gender playing field
Adds £130m assets under influence
Report on managers' attitudes towards AI
Challenge to competitors like Standard Life Aberdeen
Investment management arm up 3.9%
Plans to invest more than £3bn in strategic initiatives
Raised over £167,000